Shanghai TheraMabs Bio-technology co., LTD

Business Type:Manufacturer

Main Products:Pembrolizumab, Nivolumab, Transtuzumab

Country/Region:China

Annual Revenue:1000000 RMB

Year Established:2015

Main Markets:North America,Eastern Europe,Southeast Asia,

Ddu Verified

HOT Rank

8/10
Company Information

TheraMabs is a leading manufacturing and exporting biopharmaceutical company in therapeutic Mabs and fusion protein products in China. As an innovation-driven and customer-focused company, TheraMabs provides a broad and integrated portfolio of services throughout the therapeutic Mabs and fusion proteins R&D process. Our services are designed to help our customers shorten the discovery and development time and lower the cost of drug and medical device through cost-effective and efficient outsourcing solutions. TheraMabs has successfully established a fully integrated services and technology platform. The company built its initial capabilities around bio-process research, process development services, formulation, and biologics manufacturing services, antibody and biological research reagent manufacturing and sales and regulatory services.


We have provided many excellent products and services to lots of biopharmaceutical companies not only across China but also in many European, American and south-east Asia countries. We are striving to offer all our customers excellent products, considerate services and competitive price. 


TheraMabs offers comprehensive, integrated and open-access discovery, development, manufacturing and testing programs for recombinant proteins and monoclonal antibodies derived  from mammalian cell culture production systems. Our unique single-source  IND-enabling services encompass the entire spectrum of product development–from high throughput monoclonal antibody discovery services to clinical trials.TheraMabs’s integrated expertise and experience can streamline development efforts to achieve a faster time to clinical trials.  Our comprehensive services for mammalian-derived therapeutics – from discovery tocommercialization – including these critical areas: 


MAb Discovery 

Cell Line Development 

Bioanalytical Testing 

Assay Development & Validation 

Cell Line Characterization & GMP Cell Banking 

Process Development & Optimization 

Preclinical Sample Manufacturing 

Viral Clearance / Inactivation Studies 

GMP Manufacturing 

Product Stability Studies 


Email to this supplier
To

Send

Inquiry Cart(0)